22:13:37 EST Sat 27 Nov 2021
Enter Symbol
or Name

Login ID:
Ocumetics Technology Corp
Symbol OTC
Shares Issued 108,513,302
Close 2021-11-24 C$ 0.60
Recent Sedar Documents

Ocumetics grants option to buy 541,317 shares

2021-11-25 01:31 ET - News Release

Dr. Mark Lee reports


Ocumetics Technology Corp. has issued 541,317 incentive stock options to its newest director, Sandi Gilbert. Each option entitles the holder to purchase one common share in the capital of the corporation at an exercise price per common share of 60 cents for a period of five years. The options will vest over a period of three years, with 15 per cent of the options vesting six months after the date of issuance, another 15 per cent vesting after 12 months, another 35 per cent after 24 months and the remaining 35 per cent after 36 months.

The stock options are not transferable. The common shares issued upon exercise of the stock options will be subject to a four-month resale restriction from the date of grant.

About Ocumetics Technology Corp.

Ocumetics is a Canadian research and product development company that specializes in adaptive lens designs. Ocumetics is in the clinical trial stage of a game-changing technology for the ophthalmic industry -- the bionic lens. The bionic lens is an expandable intraocular lens that fits within the natural lens compartment of the eye to completely eliminate the need for corrective lenses. It re-establishes the natural kinetics of the eye muscles to facilitate the eye's ability to shift focus effortlessly from distance to near and very near range.

© 2021 Canjex Publishing Ltd. All rights reserved.